Table 4. Predictive accuracies of HCC for different cutoff values of pre-treatment WFA+-M2BP in different groups of patients.
Whole cohort (WFA+-M2BP ≥ 0.69 COI) | Cirrhosis-positive (WFA+-M2BP ≥ 0.69 COI) | Cirrhosis-negative (WFA+-M2BP ≥ 0.34 COI) | |
---|---|---|---|
Sensitivity | 49% | 59% | 83% |
Specificity | 84% | 76% | 61% |
Positive-predictive value | 76% | 71% | 68% |
Negative-predictive value | 62% | 65% | 78% |
HCC, hepatocellular carcinoma; WFA+-M2BP, Wisteria floribunda agglutinin positive Mac-2 binding protein.